Earnings summaries and quarterly performance for Ingersoll Rand.
Executive leadership at Ingersoll Rand.
Vicente Reynal
Chief Executive Officer and President
Andrew Schiesl
Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
Elizabeth Hepding
Senior Vice President, Corporate Development
Kathleen Keene
Senior Vice President, Chief Human Resources Officer
Matt Emmerich
Chief Information Officer
Michael Weatherred
Senior Vice President PST Segment, Demand Generation and Execution
Vikram Kini
Senior Vice President and Chief Financial Officer
Board of directors at Ingersoll Rand.
Research analysts who have asked questions during Ingersoll Rand earnings calls.
Andrew Buscaglia
BNP Paribas
6 questions for IR
Christopher Snyder
Morgan Stanley
6 questions for IR
Julian Mitchell
Barclays Investment Bank
6 questions for IR
Nigel Coe
Wolfe Research, LLC
6 questions for IR
Nathan Jones
Stifel, Nicolaus & Company, Incorporated
5 questions for IR
Andrew Kaplowitz
Citigroup
4 questions for IR
David Raso
Evercore ISI
4 questions for IR
Jeffrey Sprague
Vertical Research Partners
4 questions for IR
Michael Halloran
Baird
4 questions for IR
Nicole DeBlase
BofA Securities
4 questions for IR
Joe Ritchie
Goldman Sachs
3 questions for IR
Joseph O'Dea
Wells Fargo & Company
3 questions for IR
Robert Wertheimer
Melius Research
3 questions for IR
Stephen Volkmann
Jefferies
3 questions for IR
Jeff Sprague
Vertical Research
2 questions for IR
Joseph Ritchie
Goldman Sachs
2 questions for IR
Mike Halloran
Robert W. Baird & Co. Incorporated
2 questions for IR
Natalia
Citi
2 questions for IR
Amit Mehrotra
UBS
1 question for IR
Joe O'Day
Wells Fargo Securities
1 question for IR
Joe O'Dea
Wells Fargo
1 question for IR
Nathan Jones
Stifel
1 question for IR
Nicole DeBlase
Deutsche Bank
1 question for IR
Rob Wertheimer
Melius Research LLC
1 question for IR
Steven Volkmann
Jefferies Financial Group Inc.
1 question for IR
Recent press releases and 8-K filings for IR.
- Since the 2020 merger, Ingersoll Rand has completed 76 acquisitions and delivered $1.2–$1.3 billion in annual free cash flow across a $65 billion+ addressable market, with revenues near $8 billion.
- IR sets 0–2% organic growth guidance for 2026 to reflect prudence amid early short-cycle recovery signals, leaving room to revise if leading indicators strengthen.
- China accounts for 10% of revenue, with low-single-digit organic orders; growth drivers include replacement demand and leveraging blowers, vacuum, and air treatment technologies acquired post-merger.
- Recurring revenue reached $450 million in 2025 (up from $200 million in 2023), supported by a $1.1 billion contract backlog and targeting $1 billion by 2027.
- The company is embedding AI for predictive maintenance in connected products and enhancing sales-force efficiency, while price increases are expected to offset tariffs (price-cost neutral H1, positive H2 2026) to drive margin expansion.
- Organic growth guidance of 0–2% (midpoint 1%) for 2026 reflects a prudent view that does not yet bake in a broader industrial recovery, despite low-single-digit order momentum in H2 2025.
- Recurring revenue has ramped from ~$100 million a few years ago to >$450 million in 2026, supported by a $1.1 billion backlog of future contracts.
- Completed 16 bolt-on acquisitions in 2025 (~$275 million of acquired revenue) and targets 400–500 bps of annualized inorganic growth in 2026, with a funnel of ~200 assets and 9 LOIs.
- Regional highlights include: China at 10% of revenue with stable margins; 20% Q4 organic orders growth in non-China APAC; stable growth in Western Europe and double-digit momentum in India; and low-single-digit growth in North America bolstered by energy-efficiency tailwinds.
- ITS segment maintains 29% EBITDA margin with potential 30–40% incrementals on volume recovery, while PST margins are poised to expand triple digits in 2026 toward mid-30s by 2027, driven by life sciences growth, restructuring and early recurring-revenue adoption.
- Since the 2020 merger, Ingersoll Rand has grown to about $8 billion in revenue within a $65 billion addressable market, delivering solid organic growth, margin improvement, $1.2–1.3 billion in annual free cash flow, and completing 76 bolt-on acquisitions globally.
- For 2026, IR guides 0–2% organic growth (midpoint 1%), taking a prudent view that excludes a broad industrial recovery, and expects pricing to be tariff-neutral in H1 before driving margin expansion in H2.
- Short-cycle orders in ITS showed low single-digit momentum in H2 2025, while under-penetrated markets (Latin America, Middle East, India, Southeast Asia) benefit from new facilities and commercial investments; Europe remains stable with sustainability demand, and Americas growth is supported by life sciences and higher energy costs.
- ITS maintained ~29% EBITDA margins in 2025 and could realize 30–40% incrementals on incremental volume; PST margins exceeded 30% with a path to mid-30s by 2027 through volume growth, restructuring actions, recurring revenue initiatives, and bolt-on M&A.
- The M&A engine remains active: IR closed 16 deals in 2025 adding $275 million of acquired revenue, and targets 4–5% annual inorganic growth via a 90% sole-sourced bolt-on approach across ITS, PST, and life sciences.
- Q4 saw positive organic order growth in North America and China, and 20%+ order growth in non-China Asia, but management remains prudent awaiting sustained recovery.
- 2026 guidance forecasts 1% organic revenue growth and 5% EPS growth at midpoint, with typical seasonal phasing (Q1 lightest, Q4 heaviest; H1 and H2 mid-single-digit earnings growth).
- Recurring revenue reached $450 M in 2025 (vs. ~$200 M in 2023), driven by PackageCARE and analogous service models across compressors, blowers, and pumps, with broad global adoption.
- Tariff headwinds (Section 232 and other duties) have been offset dollar-for-dollar via pricing, causing H1 margin pressure but expected normalization and margin expansion in H2 2026.
- Capital allocation: ~80% of free cash flow targeted to M&A (bolt-on deals around $1 B plus smaller acquisitions), $300–350 M planned for share repurchases, and dividend unchanged.
- Guidance for 2026 assumes ~1% organic revenue growth and ~5% EPS growth at the midpoints, with customary seasonal phasing (light Q1, heavy Q4).
- Recurring revenue more than doubled to $450 million in 2025 (from $200 million in 2023 and $100 million earlier), now spanning all nine business units on track towards a $1 billion target.
- Industrial Technologies & Services (ITS) margins are planned at ~29%, with tariff-related headwinds expected in H1 2026 and normalization (margin expansion) in H2 2026; Precision & Science Technologies (PST) margins are improving through integration and productivity initiatives, aiming for mid-30s% EBITDA over time.
- Capital deployment prioritizes bolt-on M&A (~80–85% of free cash flow, including $500 million across 16 deals in 2025 and $1 billion+ transactions in the pipeline), complemented by $300–350 million in share buybacks and a stable dividend.
- Q4 2025 saw positive organic orders growth in North America and China; 2026 guidance calls for 1% organic growth midpoint and ~5% EPS growth, with seasonal phasing in H1/H2 similar to prior years.
- Recurring revenue surpassed $450 million in 2025 (versus $200 million in 2023), driven by Package Care and new recurring‐revenue models; gross margins on risk-transfer offerings run 60–70%, with a $1 billion target by 2027.
- U.S. compressor tariffs are offset dollar-for-dollar by pricing actions, resulting in price-cost neutrality; first-half 2026 ITS margin headwind expected to normalize in H2 2026.
- ITS EBITDA margin forecast at ~29% for 2026 with potential low-single-digit expansion thereafter; PST margins set to improve by >1 percentage point in 2026, aiming for mid-30s% over time.
- Capital allocation prioritizes M&A (targeting 80–85% of free cash flow for bolt-on deals, including $1 billion+ transactions), $300–350 million in share buybacks, and an unchanged dividend.
- Q4 orders up 8% YoY (1% organic); revenue +10% YoY (3% organic); adjusted EBITDA $580 M (27.7% margin); EPS $0.96 (+14% YoY)
- FY2025 orders +9% YoY (1% organic); revenue +6% YoY (organic –1%); adjusted EBITDA $2.1 B (27.4% margin); EPS $3.34 (+2% YoY)
- Free cash flow $462 M in Q4; liquidity $3.8 B; leverage <2×; deployed $525 M on M&A, $1 B on share repurchases, $32 M in dividends
- 2026 guidance: revenue +2.5–4.5% (organic +1% at midpoint); adjusted EBITDA $2.13–2.19 B; adjusted EPS $3.45–3.57
- In Q4 and full-year 2025, Ingersoll Rand delivered low single-digit organic order growth and returned to organic revenue growth.
- Recurring revenue exceeded $450 million in 2025, with a backlog of approximately $1.1 billion in future revenue from existing contracts.
- ITS segment Q4 orders were up 9%, revenue grew 11%, and Adjusted EBITDA margin was 28.9%; PST segment Q4 orders rose 6%, revenue increased 8%, and Adjusted EBITDA margin reached 30.4%.
- For 2026, the company guides to 2.5–4.5% revenue growth, driven by 1% organic growth, 1.5% from M&A carryover, and 1% FX tailwind.
- In Q4 2025, orders rose 8% to $1,951.7 M and revenue increased 10% to $2,091.2 M, with organic revenue up 3% year-over-year.
- Adjusted EBITDA grew 9% to $580.1 M, though margin contracted 30 bps to 27.7%; adjusted diluted EPS was $0.96, up 14%.
- Q4 free cash flow was $461.5 M, representing a 22.1% free cash flow margin.
- The company invested $525 M in inorganic growth in FY 2025, closing 16 transactions and acquiring ~$275 M of annualized revenue, while guiding FY 2026 for 2.5%–4.5% revenue growth, $2,130 M–$2,190 M adjusted EBITDA, and $3.45–$3.57 adjusted EPS.
- Q4 orders rose 8% year-over-year (up 1% organically) with a book-to-bill of 0.93; full-year orders increased 9% (1% organic) reflecting broad segment strength.
- Q4 revenue was up 10% (organic + 3%), delivering adjusted EBITDA of $580 million (27.7% margin) and adjusted EPS of $0.96, a 14% increase.
- For full-year 2025, adjusted EBITDA reached $2.1 billion (27.4% margin) with adjusted EPS of $3.34 (+ 2%); Q4 free cash flow was $462 million and capital deployment included $525 million in M&A, $1 billion in buybacks, and $32 million in dividends.
- The recurring revenue initiative surpassed $450 million in 2025 with a $1.1 billion backlog; M&A spend of $525 million across 16 deals generated $275 million in annualized revenue. 2026 guidance calls for revenue growth of 2.5–4.5%, adjusted EBITDA of $2.13–2.19 billion, and EPS of $3.45–3.57.
Quarterly earnings call transcripts for Ingersoll Rand.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more